Press Release

Global Cancer Informatics market is expected to grow at a CAGR of 7.5% during 2021-26

According to the MarkNtel Advisors' research report, "Global Cancer Informatics Market Analysis, 2021," the market is likely to grow at a CAGR of 7.5% during 2021-26 due to the rising adoption of cancer-specific Electronic Health Records (EHRs) for monitoring & recording health-related data of patients. Besides, the growing number of cancer patients and high costs associated with cancer treatment further fuel the market growth. Growing developments in the healthcare industry upturn the need for data collection & analysis. Hence, the demand for adequate information systems increases, thereby providing lucrative growth opportunities for the market.

Key questions answered in the study

1. What are the current and future trends in the Global Cancer Informatics market?
2. How has the industry been evolving in terms of geography and services adoption?
3. How has the competition been shaping across the countries, followed by their comparative factorial indexing?
4. What are the key growth drivers and challenges for the Global Cancer Informatics market?
5. What are the customer orientation, purchase behavior, and expectations from the Global Cancer Informatics market service provider across various regions?

Pharmaceutical Industry Exhibits Fastest Growth

Based on the End-user outlook, the pharmaceutical industry is likely to witness the fastest growth during the forecast period due to rising demand for the increased workflow of facilities and enhancing the quality of care. In addition to this, the mounting requirement of patient-centric treatment to receive high-quality care is propelling the market growth. Moreover, the increasing trend of personalized medicine could use the information to find an efficient approach toward prescribed doses, thereby providing growth opportunities to the market.

“Global Cancer Informatics Market Analysis, 2021” provides comprehensive, qualitative, and quantitative insights on the market potential, key factors impacting the market growth, hotspots, and opportunities available for Cancer Informatics providers across the globe. Moreover, the report also encompasses the key strategic imperatives for competitors' success and strategic factorial indexing to measure their capabilities on 16 parameters, which will help companies formulate 'Go to Market' strategies and identify the blue ocean for their offerings.

Asia-Pacific Exhibits Fastest Growth

The Asia-pacific market is likely to register the fastest growth in the Global Cancer Informatics market during 2021-26. Cancer with the highest level of mutation is highly prevalent in the Asia-Pacific region. Further, changing lifestyle and rising smoking & drinking habits have led to increasing cancer occurrences among people. Therefore, Asia-Pacific is likely to contribute to the growth of the global Cancer Informatics market in the forecast period, reveals MarkNtel Advisors in their research report, "Global Cancer Informatics Market Analysis, 2021."

According to MarkNtel Advisors, the major leading players in the global Cancer Informatics market are Elekta ab, Varian Medical Systems, Accuray Incorporated, Cerner Corporation, RaySearch Laboratories, Flatiron, Oncology Analytics, Inc, Hologic Inc., F.Hoffmann-La Roche Ltd., McKesson Corporation, etc.

Market Segmentation:

1. By Product (Electronic Health Records (EHRs), Population Health Management (PHM), Clinical Decision Support System (CDSS), Drug Discovery and Development Informatics (DDDI))
2. By Application (Medical Application, Surgical Application, Radiation Application)
3. By Cancer Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Other)
4. By End-Users (Life Science industry, Academic Institutes, and Research Centers, Pharmaceutical Companies, Contract Research Organizations (CROs), Others (Hospitals and Other Care Facilities))
5. By Region (North America, South America, Europe, Asia-Pacific, Middle East & Africa)
6. By Country (US, Canada, Mexico, Brazil, UK, Italy, Germany, France, Russia, Spain, Saudi-Arabia, South-Africa, China, India, Japan, South-Korea, Australia)
7. By Competitors (Elekta ab, Varian Medical Systems, Accuray Incorporated, Cerner Corporation, RaySearch Laboratories, Flatiron, Oncology Analytics, Inc, Hologic Inc., F.Hoffmann-La Roche Ltd., McKesson Corporation)